Use of bone-modifying agents in myeloma and bone metastases: How recent dosing interval studies have affected our practice

Erica Campagnaro, Melissa A. Reimers, Angel Qin, Ajjai S. Alva, Bryan J. Schneider, Catherine H. Van Poznak

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Use of bone-modifying agents in myeloma and bone metastases: How recent dosing interval studies have affected our practice'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences